Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Exp Anim ; 62(4): 295-304, 2013.
Article in English | MEDLINE | ID: mdl-24172193

ABSTRACT

The Cre/loxP system is a strategy for controlling temporal and/or spatial gene expression through genome alteration in mice. As successful Cre/loxP genome alteration depends on Cre-driver mice, Cre-reporter mice are essential for validation of Cre gene expression in vivo. In most Cre-reporter mouse strains, although the presence of reporter product indicates the expression of Cre recombinase, it has remained unclear whether a lack of reporter signal indicates either no Cre recombinase expression or insufficient reporter gene promoter activity. We produced a novel ROSA26 knock-in Cre-reporter C57BL/6N strain exhibiting green emission before and red after Cre-mediated recombination, designated as strain R26GRR. Ubiquitous green fluorescence and no red fluorescence were observed in R26GRR mice. To investigate the activation of tdsRed, EGFP-excised R26GRR, R26RR, mice were produced through the crossing of C57BL/6N mice with R26GRR/Ayu1-Cre F1 mice. R26RR mice showed extraordinarily strong red fluorescence in almost all tissues examined, suggesting ubiquitous activation of the second reporter in all tissues after Cre/loxP recombination. Moreover, endothelial cell lineage and pancreatic islet-specific expression of red fluorescence were detected in R26GRR/Tie2-Cre F1 mice and R26GRR /Ins1-Cre F1 mice, respectively. These results indicated that R26GRR mice are a useful novel Cre-reporter mouse strain. In addition, R26GRR mice with a pure C57BL/6N background represent a valuable source of green-to-red photoconvertible cells following Cre/loxP recombination for application in transplantation studies. The R26GRR mouse strain will be available from RIKEN BioResource Center (http://www.brc.riken.jp/lab/animal/en/).


Subject(s)
Gene Expression , Genes, Reporter/genetics , Genes, Reporter/physiology , Green Fluorescent Proteins/metabolism , Integrases/genetics , Integrases/metabolism , Animals , Cells, Cultured , Embryonic Stem Cells , Endothelial Cells/metabolism , Female , Gene Knock-In Techniques , Islets of Langerhans/metabolism , Luminescent Proteins , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Recombination, Genetic , Ubiquitination , Red Fluorescent Protein
2.
J Reprod Dev ; 59(6): 599-603, 2013 Dec 17.
Article in English | MEDLINE | ID: mdl-23979397

ABSTRACT

Somatic cell nuclear transfer (SCNT) is a useful technique for creating pig strains that model human diseases. However, production of numerous cloned disease model pigs by SCNT for large-scale experiments is impractical due to its complexity and inefficiency. In the present study, we aimed to establish an efficient procedure for proliferating the diabetes model pig carrying the mutant human hepatocyte nuclear factor-1α gene. A founder diabetes transgenic cloned pig was generated by SCNT and treated with insulin to allow for normal growth to maturity, at which point epididymal sperm could be collected for cryopreservation. In vitro fertilization and intrafallopian insemination using the cryopreserved epididymal sperm resulted in diabetes model transgenic offspring. These results suggest that artificial reproductive technology using cryopreserved epididymal sperm could be a practical option for proliferation of genetically modified disease model pigs.


Subject(s)
Cryopreservation/veterinary , Diabetes Mellitus/veterinary , Disease Models, Animal , Fertilization in Vitro/veterinary , Insemination, Artificial/veterinary , Spermatozoa , Swine Diseases/genetics , Animals , Animals, Genetically Modified , Cloning, Organism/veterinary , Diabetes Mellitus/drug therapy , Diabetes Mellitus/genetics , Female , Hepatocyte Nuclear Factor 1-alpha/genetics , Hepatocyte Nuclear Factor 1-alpha/metabolism , Humans , Hypoglycemic Agents/therapeutic use , Japan , Male , Mutation , Nuclear Transfer Techniques/veterinary , Pregnancy , Sus scrofa , Swine , Swine Diseases/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL